Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 25954 | 267 | 35.0 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
| 143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
| 230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
| 25954 | 1 | STAVANGER NEUROL UNIT//ADDUCTION LAG//AGE ACCELERATED ATHEROSCLEROSIS | 267 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | STAVANGER NEUROL UNIT | address | 171544 | 1% | 50% | 3 |
| 2 | ADDUCTION LAG | authKW | 114364 | 0% | 100% | 1 |
| 3 | AGE ACCELERATED ATHEROSCLEROSIS | authKW | 114364 | 0% | 100% | 1 |
| 4 | AL JAWHARAH MOL MED | address | 114364 | 0% | 100% | 1 |
| 5 | ANA BILIM DALI | address | 114364 | 0% | 100% | 1 |
| 6 | AREA GEST INTE A VIGO | address | 114364 | 0% | 100% | 1 |
| 7 | ATHEROSCLEROSIS UNIT DEV | address | 114364 | 0% | 100% | 1 |
| 8 | C677T METHYLENETETRAHYDROFOLATE REDUCTASE GENE | authKW | 114364 | 0% | 100% | 1 |
| 9 | CARBAMAZEPINE MONOTHERAPY | authKW | 114364 | 0% | 100% | 1 |
| 10 | CHILDREN VALPROATE | authKW | 114364 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Clinical Neurology | 3099 | 47% | 0% | 125 |
| 2 | Pharmacology & Pharmacy | 377 | 24% | 0% | 63 |
| 3 | Pediatrics | 193 | 10% | 0% | 27 |
| 4 | Medical Laboratory Technology | 95 | 3% | 0% | 9 |
| 5 | Neurosciences | 92 | 13% | 0% | 35 |
| 6 | Medicine, General & Internal | 37 | 7% | 0% | 19 |
| 7 | Psychiatry | 35 | 5% | 0% | 14 |
| 8 | Behavioral Sciences | 24 | 3% | 0% | 7 |
| 9 | Nutrition & Dietetics | 21 | 3% | 0% | 8 |
| 10 | Toxicology | 20 | 3% | 0% | 9 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | STAVANGER NEUROL UNIT | 171544 | 1% | 50% | 3 |
| 2 | AL JAWHARAH MOL MED | 114364 | 0% | 100% | 1 |
| 3 | ANA BILIM DALI | 114364 | 0% | 100% | 1 |
| 4 | AREA GEST INTE A VIGO | 114364 | 0% | 100% | 1 |
| 5 | ATHEROSCLEROSIS UNIT DEV | 114364 | 0% | 100% | 1 |
| 6 | CLIN CHEM LSP1 | 114364 | 0% | 100% | 1 |
| 7 | CLIN SAMSUNG MED EPILEPSY PROGRAM | 114364 | 0% | 100% | 1 |
| 8 | CLIN SAMSUNG MED FAMILY MED | 114364 | 0% | 100% | 1 |
| 9 | CLIN SAMSUNG MED NEUROL | 114364 | 0% | 100% | 1 |
| 10 | KLIN POLIKLIN KINDER JUGENDSPSYCHIAT ULM | 114364 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EPILEPSY RESEARCH | 14296 | 8% | 1% | 22 |
| 2 | EPILEPSIA | 8674 | 10% | 0% | 26 |
| 3 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 5689 | 4% | 0% | 11 |
| 4 | JOURNAL OF CHILD NEUROLOGY | 1499 | 3% | 0% | 8 |
| 5 | EPILEPSY & BEHAVIOR | 1365 | 3% | 0% | 7 |
| 6 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1024 | 3% | 0% | 8 |
| 7 | PEDIATRIC NEUROLOGY | 964 | 2% | 0% | 6 |
| 8 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 923 | 1% | 0% | 3 |
| 9 | ACTA NEUROLOGICA SCANDINAVICA | 915 | 3% | 0% | 7 |
| 10 | NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 838 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LOPINTO-KHOURY, C , MINTZER, S , (2010) ANTIEPILEPTIC DRUGS AND MARKERS OF VASCULAR RISK.CURRENT TREATMENT OPTIONS IN NEUROLOGY. VOL. 12. ISSUE 4. P. 300-308 | 34 | 67% | 28 |
| 2 | VYAS, MV , DAVIDSON, BA , ESCALAYA, L , COSTELLA, J , SAPOSNIK, G , BURNEO, JG , (2015) ANTIEPILEPTIC DRUG USE FOR TREATMENT OF EPILEPSY AND DYSLIPIDEMIA: SYSTEMATIC REVIEW.EPILEPSY RESEARCH. VOL. 113. ISSUE . P. 44 -67 | 29 | 60% | 8 |
| 3 | KEENAN, N , SADLIER, LG , WILTSHIRE, E , (2014) VASCULAR FUNCTION AND RISK FACTORS IN CHILDREN WITH EPILEPSY: ASSOCIATIONS WITH SODIUM VALPROATE AND CARBAMAZEPINE.EPILEPSY RESEARCH. VOL. 108. ISSUE 6. P. 1087 -1094 | 26 | 63% | 6 |
| 4 | MEHRPOUR, M , SHOJAIE, M , ZAMANI, B , GHARIBZADEH, S , ABBASI, M , (2014) ATHEROGENIC CONSEQUENCE OF ANTIEPILEPTIC DRUGS: A STUDY OF INTIMA-MEDIA THICKNESS.NEUROLOGICAL SCIENCES. VOL. 35. ISSUE 2. P. 253-257 | 21 | 81% | 1 |
| 5 | JAKUBUS, T , MICHALSKA-JAKUBUS, M , LUKAWSKI, K , JANOWSKA, A , CZUCZWAR, SJ , (2009) ATHEROSCLEROTIC RISK AMONG CHILDREN TAKING ANTIEPILEPTIC DRUGS.PHARMACOLOGICAL REPORTS. VOL. 61. ISSUE 3. P. 411 -423 | 45 | 41% | 17 |
| 6 | EL-FARAHATY, RM , EL-MITWALLI, A , AZZAM, H , WASEL, Y , ELRAKHAWY, MM , HASANEEN, BM , (2015) ATHEROSCLEROTIC EFFECTS OF LONG-TERM OLD AND NEW ANTIEPILEPTIC DRUGS MONOTHERAPY: A CROSS-SECTIONAL COMPARATIVE STUDY.JOURNAL OF CHILD NEUROLOGY. VOL. 30. ISSUE 4. P. 451 -457 | 22 | 63% | 4 |
| 7 | CASTRO-GAGO, M , NOVO-RODRIGUEZ, MI , BLANCO-BARCA, MO , DE CORTAZAR, AUR , RODRIGUEZ-GARCIA, J , RODRIGUEZ-SEGADE, S , EIRIS-PUNAL, J , (2006) EVOLUTION OF SERUM LIPIDS AND LIPOPROTEIN (A) LEVELS IN EPILEPTIC CHILDREN TREATED WITH CARBAMAZEPINE, VALPROIC ACID, AND PHENOBARBITAL.JOURNAL OF CHILD NEUROLOGY. VOL. 21. ISSUE 1. P. 48-53 | 25 | 69% | 16 |
| 8 | GORJIPOUR, F , ASADI, Y , OSGUEI, NK , EFFATKHAH, M , SAMADIKUCHAKSARAEI, A , (2013) SERUM LEVEL OF HOMOCYSTEINE, FOLATE AND VITAMIN-B12 IN EPILEPTIC PATIENTS UNDER CARBAMAZEPINE AND SODIUM VALPROATE TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS.IRANIAN RED CRESCENT MEDICAL JOURNAL. VOL. 15. ISSUE 3. P. 249 -253 | 16 | 89% | 5 |
| 9 | COPPOLA, G , INGROSSO, D , OPERTO, FF , SIGNORIELLO, G , LATTANZIO, F , BARONE, E , MATERA, S , VERROTTI, A , (2012) ROLE OF FOLIC ACID DEPLETION ON HOMOCYSTEINE SERUM LEVEL IN CHILDREN AND ADOLESCENTS WITH EPILEPSY AND DIFFERENT MTHFR C677T GENOTYPES.SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. VOL. 21. ISSUE 5. P. 340-343 | 18 | 78% | 9 |
| 10 | TOMOUM, HY , AWADALLAH, MM , FOUAD, DA , ALI, AH , (2008) LIPID PROFILE, APOLIPOPROTEINS A AND B IN CHILDREN WITH EPILEPSY.JOURNAL OF CHILD NEUROLOGY. VOL. 23. ISSUE 11. P. 1275-1281 | 20 | 74% | 9 |
Classes with closest relation at Level 1 |